Search results for: Baylor University Medical Center

Baylor Scott & White researchers identify a novel site for islet cell transplantation

Patients experiencing the intractable pain of chronic pancreatitis may be candidates for total pancreatectomy followed by autologous islet cell transplantation (TPIAT). This innovative procedure has been documented to be very effective in controlling pain and restoring insulin secretion in a large number of patients. Baylor University Medical Center, (Baylor Dallas) part of Baylor Scott & White Health, has performed more than 200 successful islet cell transplants, placing it among the top five centers in the United States based on total case volume of this procedure.

Read more

Research from Baylor Scott & White featured in updated gastroesophageal reflux disease clinical guidelines

Gastroesophageal reflux disease (GERD) is estimated to affect nearly 20% of Americans. Recent advances in our understanding of GERD have changed clinical practice. Therefore, in February 2022, the American College of Gastroenterology (ACG) released an updated set of guidelines for the diagnosis and management of GERD. Research from Baylor University Medical Center (Baylor Dallas), part of Baylor Scott & White Health, helped shape these new practice guidelines.

Read more

#ReviveTheSwan – The importance of right heart catheterization in advanced heart failure

Placement of a pulmonary artery catheter (PAC), commonly known as a Swan-Ganz catheter, provides hemodynamic data that is vital for clinicians treating patients with acute decompensated heart failure or cardiogenic shock.  While routine use has been shown to not be beneficial, there are many instances in which hemodynamic monitoring through the use of a Swan is highly indicated.

Read more

SGLT2 inhibitors reduce heart failure hospitalizations and cardiovascular deaths in diabetic patients

Heart failure and diabetes are closely intertwined.  Diabetes affects not only coronary artery blood flow, but also the myocardium. Patients with type 2 diabetes are at risk of heart failure due to intrinsic myocardial disease, resulting in increased myocardial hypertrophy, fibrosis and stiffness. This can also lead to a form of heart failure described in literature as diabetic cardiomyopathy.

Read more